Abstract:ETHNOPHARMACOLOGICAL RELEVANCE: Borneol is widely used in traditional Chinese medicine to facilitate the distribution of central nervous system (CNS) drugs in brain due to its ability to open blood-brain barrier (BBB), however, the underlying mechanism is still unclear. In this study, the effect of borneol on different brain regions were investigated to explore the mechanism.MATERIALS AND METHODS: After oral administration of borneol (0.1, 0.2 g/kg) for seven consecutive days, SD rats were injected with Rh123 (1.0 mg/kg). The concentrations of Rh123 were detected in four brain regions of cortex, hippocampus, hypothalamus and striatum by a small animal vivo imaging system and a fluorescence microplate reader respectively. The ultrastructures of BBB were examined. Moreover, the expressions of the four transporters of ATP-binding cassette (ABC) family, multidrug resistance 1a (Mdr1a), multidrug resistance 1b (Mdr1b), multidrug resistance protein 1 (Mrp1), Mrp4, Mrp5 and breast cancer resistance protein (Bcrp) in the four brain regions were analyzed. Finally, the deliveries of borneol in the plasma and the four brain regions were examined by a pharmacokinetics study.RESULTS: Administration of 0.2 g/kg borneol produced loose structure in the tight junction and void structure between the endothelial cell and mesangial cell. Borneol at 0.1 g/kg and 0.2 g/kg increased the delivery of Rh123 in hippocampus and hypothalamus obviously. Permeability index followed a similar trend. Protein expression assays showed that borneol decreased the expression of Mdr1 and Mrp1 in hippocampus and hypothalamus. Further RT-PCR study showed that borneol decreased the expressions of both Mdr1a and Mdr1b in hippocampus and hypothalamus. The pharmacokinetics study demonstrated that the delivery of borneol in cortex was the most and that in striatum the least, with the deliveries of borneol in hippocampus and hypothalamus in between.CONCLUSIONS: Borneol showed tissue specific BBB-opening effect, which was associated with its regulation of the ultrastructure of brain tissues and the expressions of Mdr1a, Mdr1b and Mrp1. The present study indicated that borneol should be used in concert with drugs targeting hippocampus or hypothalamus to exert its synergistic effect to the maximum.

Transport and Metabolism Behavior of Brazilein During Its Entrance into Neural Cells

[Effect of Brazilein on Energy Metabolism of Cerebral Ischemia-Reperfusion in Mice].

Brazilein protects the brain against focal cerebral ischemia reperfusion injury correlating to inflammatory response suppression.

In Silico Modeling on ADME Properties of Natural Products: Classification Models for Blood-Brain Barrier Permeability, Its Application to Traditional Chinese Medicine and in Vitro Experimental Validation

Brazilein Inhibits Neuronal Inflammation Induced by Cerebral Ischemia and Oxygen-Glucose Deprivation Through Targeting NOD2 Expression.

Metabolites and Metabolic Pathway Analysis of Brazilin in Rats by UPLC-Q-TOF-MS/MS

Study on Cardioactive Effects of Brazilein

Effect of Brazilein on Relaxation of Vascular Smooth Muscle of Rat

Development And Optimization Of A Method For The Analysis Of Brazilein By Hplc With Electrochemical Detection

Reproductive Toxicity of Brazilein in Icr Mice

Borneol, a messenger agent, improves central nervous system drug delivery through enhancing blood-brain barrier permeability: a preclinical systematic review and meta-analysis

Brazilin Inhibits Amyloid Β-Protein Fibrillogenesis, Remodels Amyloid Fibrils and Reduces Amyloid Cytotoxicity

LC-MS/MS metabolomic profiling of the protective butylphthalide effect in cerebral ischemia/reperfusion mice.

Circulating low-molecular-weight (poly)phenol metabolites in the brain: unveiling in vitro and in vivo blood-brain barrier transport

The Barrier and Interface Mechanisms of the Brain Barrier, and Brain Drug Delivery.

Circulating (poly)phenol metabolites in the brain: unveiling in vitro and in vivo blood-brain barrier transport

The mechanism of the opening of the blood–brain barrier by borneol: A pharmacodynamics and pharmacokinetics combination study

Molecular docking of brazilin and its analogs to barrier-to-autointegration factor 1 (BAF1)

Brazilin Removes Toxic Alpha-Synuclein and Seeding Competent Assemblies from Parkinson Brain by Altering Conformational Equilibrium

Determination of Brazilein in Rat Plasma after Intravenous Administration by HPLC

Study on the Plasma Binding Rate of Brazilein